343 related articles for article (PubMed ID: 2484772)
1. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
Saito Y; Shinomiya M; Shirai K; Yoshida S
Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
[No Abstract] [Full Text] [Related]
2. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
[TBL] [Abstract][Full Text] [Related]
3. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis.
Jones PH
Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769
[No Abstract] [Full Text] [Related]
4. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.
Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G
Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770
[No Abstract] [Full Text] [Related]
5. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
Mabuchi H; Higashikata T; Kawashiri MA
Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
[TBL] [Abstract][Full Text] [Related]
7. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
[No Abstract] [Full Text] [Related]
8. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
9. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T
Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185
[TBL] [Abstract][Full Text] [Related]
10. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
[No Abstract] [Full Text] [Related]
11. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
Zwiener RJ; Uauy R; Petruska ML; Huet BA
J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
[TBL] [Abstract][Full Text] [Related]
12. A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin.
Shiina Y; Homma Y; Oguma T; Fusegawa Y; Ozawa H; Handa S; Tanabe T
Tokai J Exp Clin Med; 2005 Sep; 30(3):149-55. PubMed ID: 16285605
[TBL] [Abstract][Full Text] [Related]
13. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396
[TBL] [Abstract][Full Text] [Related]
14. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
Mol MJ; Stalenhoef AF
Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
[TBL] [Abstract][Full Text] [Related]
15. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B
Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773
[No Abstract] [Full Text] [Related]
16. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
17. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
18. Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab.
Tanaka A; Inaguma D; Watanabe Y; Ito E; Kamegai N; Shimogushi H; Shinjo H; Koike K; Otsuka Y; Takeda A
Intern Med; 2017; 56(12):1531-1535. PubMed ID: 28626179
[TBL] [Abstract][Full Text] [Related]
19. Long term effect of LDL apheresis on coronary heart disease.
Donner MG; Richter WO; Schwandt P
Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655
[TBL] [Abstract][Full Text] [Related]
20. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
